With wide clinical demands, therapies for traumatic brain
injury
(TBI) are a major problem in surgical procedures and after major trauma.
Due to the difficulty in regeneration of neurons or axons after injury,
as well as the inhibition of blood vessel growth by the formation
of neural scars, existing treatment measures have limited effectiveness
in repairing brain tissue. Herein, the biomultifunctional hydrogels
are developed for TBI treatment based on the Schiff base reaction
of calcium ion (Ca2+)-cross-linked oxidized sodium alginate
(OSA) and carboxymethyl chitosan (CMCS). The obtained COCS hydrogel
exhibits excellent adhesion to wet tissues, self-repair capability,
and antimicrobial properties. What’s particularly interesting
is that the addition of Ca2+ increases the hydrogel’s
extensibility, enhancing its hemostatic capabilities. Biological assessments
indicate that the COCS hydrogel demonstrates excellent biocompatibility,
hemostatic properties, and the ability to promote arterial vessel
repair. Importantly, the COCS hydrogel promotes the growth of cerebral
microvessels by upregulating CD31, accelerates the proliferation of
astrocytes, enhances the expression of GFAP, and stimulates the expression
of neuron-specific markers such as NEUN and β-tubulin. All of
these findings highlight that the strongly adhesive, self-healing,
hemostatic hydrogel shows great potential for the repair of traumatic
brain injury and other tissue repair therapy.